Genmab A/S (GMAB)
26.10
-0.69
(-2.58%)
USD |
NASDAQ |
Apr 29, 16:00
26.10
0.00 (0.00%)
After-Hours: 20:00
Genmab Market Cap : 16.08B for April 29, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novo Nordisk A/S | 178.61B |
| Johnson & Johnson | 547.28B |
| Ascendis Pharma A/S | 13.61B |
| Zealand Pharma A/S | 3.460B |
| Bavarian Nordic A/S | 2.239B |
Market Cap Related Metrics
| PE Ratio | 16.86 |
| PS Ratio | 4.460 |
| Price to Book Value | 2.750 |
| Price to Free Cash Flow | 14.65 |
| Price | 26.10 |
| Earnings Yield | 5.93% |
| Operating PE Ratio | 13.27 |
| Normalized PE Ratio | 15.00 |